INTS vs WAT
Intensity Therapeutics, Inc. Common stock (INTS) versus Waters Corporation (WAT) — a side-by-side from cached financials, not a winner call.
Intensity Therapeutics, Inc. Common stock (INTS) is a biotechnology company listed on US.
Waters Corporation (WAT) is a diagnostics & research company listed on US.
INTS does not have a complete income-statement cache yet.
Latest reported WAT revenue for 2024-12-31 was $872.7M. Net income was $637.8M. Revenue was up 17.9% from 2024-09-30 to 2024-12-31. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
INTS currently screens at market cap $7.7M. WAT currently screens at market cap $20.84B and trailing P/E 31.8.
Not investment advice. Open the INTS and WAT stock pages for the full models.
Not investment advice.